Journal article
Oseltamivir for Treatment of Influenza in Healthy Adults: Pooled Trial Evidence and Cost-Effectiveness Model for Canada
Abstract
BACKGROUND: Influenza is a common viral respiratory infection that is associated with significant morbidity. Oseltamivir (Tamiflu) is a neuraminidase inhibitor-a new class of antiviral treatment for influenza where efficacy and safety has been established but cost-effectiveness is unknown.
METHODS: A decision analytic model was used to estimate the costs and effectiveness of two treatment scenarios for empiric management of otherwise healthy …
Authors
O'Brien BJ; Goeree R; Blackhouse G; Smieja M; Loeb M
Journal
Value in Health, Vol. 6, No. 2, pp. 116–125
Publisher
Elsevier
Publication Date
March 2003
DOI
10.1046/j.1524-4733.2003.00213.x
ISSN
1098-3015